<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898714</url>
  </required_header>
  <id_info>
    <org_study_id>FUTURE-59342</org_study_id>
    <nct_id>NCT02898714</nct_id>
  </id_info>
  <brief_title>Flash Glucose Monitoring Study for Diabetes</brief_title>
  <acronym>FUTURE</acronym>
  <official_title>The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the first of July 2016, the Freestyle Libre Flash Glucose Monitor (FGM) will be reimbursed
      in Belgium by means of a new diabetes reimbursement program for adults. For children, the
      Freestyle Libre FGM is also reimbursed by means of a new reimbursement program from the first
      of August 2016 onwards. Making this the only way to receive the device in Belgium. To
      understand the impact of this new FGM on diabetes patients in UZ Leuven and OLVZ Aalst, we
      want to study the use of the device by our patients by means of an observational study where
      patients complete questionnaires at regular time points in the first year of usage and after
      24 months Clinical data will be gathered during the routine clinical visits as part of the
      reimbursement program.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical care parameters</measure>
    <time_frame>3 years</time_frame>
    <description>Change in HbA1c</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 4 years with diabetes using FGM after entering in the new diabetes
        reimbursement program in Belgium in UZ Leuven and OLVZ Aalst.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  &gt;= 4 years

          -  Using flash glucose monitoring

        Exclusion Criteria:

          -  Doesn't want ot sign the nformed consent

          -  &lt; 4 years

          -  Not using flash glucose monitoring
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pieter Gillard, MD, PhD</last_name>
    <email>pieter.gillard@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Charleer, MA</last_name>
    <email>sara.charleer@kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Gillard, MD, PhD</last_name>
      <email>pieter.gillard@uzleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Sara Charleer, MA</last_name>
      <email>sara.charleer@kuleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Pieter Gillard, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>January 12, 2018</last_update_submitted>
  <last_update_submitted_qc>January 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>prof dr Pieter Gillard</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

